GurevitzSLSnyderJAWesselEKFreyJWilliamsonBA. Systemic lupus erythematosus: A review of the disease and treatment options. Consult Pharm2013; 28: 110–121.
2.
CookeA. Review series on helminths, immune modulation and the hygiene hypothesis: How might infection modulate the onset of type 1 diabetes?Immunology2009; 126: 12–17.
3.
PandaAKRavindranBDasBK. Rheumatoid arthritis patients are free of filarial infection in an area where filariasis is endemic: Comment on the article by Pineda et al. Arthritis Rheum2013; 65: 1402–1403.
4.
PandaAKSahooPKKerkettaASKarSKRavindranBSatapathyAK. Human lymphatic filariasis: Genetic polymorphism of endothelin-1 and tumor necrosis factor receptor II correlates with development of chronic disease. J Infect Dis2011; 204: 315–322.
5.
BabuBVAcharyaASMallickGJangidPKNayakANSatyanarayanaK. Lymphatic filariasis in Khurda district of Orissa, India: An epidemiological study. Southeast Asian J Trop Med Public Health2001; 32: 240–243.
6.
AravindhanVMohanVSurendarJ. Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes. Am J Trop Med Hyg2010; 83: 1336–1339.
7.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
8.
GassKBeau de RocharsMVBoakyeD. A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. PLoS Negl Trop Dis2012; 6: e1479–e1479.
9.
ChanteauSMoulia-PelatJPGlaziouP. Og4C3 circulating antigen: A marker of infection and adult worm burden in Wuchereria bancrofti filariasis. J Infect Dis1994; 170: 247–250.
10.
HarnettMMMelendezAJHarnettW. The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease. Clin Exp Immunol2010; 159: 256–267.
11.
KamgnoJDjomoPNPionSDThyleforsBBoussinesqM. A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia. Am J Trop Med Hyg2010; 82: 379–385.
12.
PinedaMAMcGrathMASmithPC. The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites. Arthritis Rheum2012; 64: 3168–3178.
13.
NalbandianACrispinJCTsokosGC. Interleukin-17 and systemic lupus erythematosus: Current concepts. Clin Exp Immunol2009; 157: 209–215.
